Real World Experience of Ustekinumab for Induction and Maintenance of Remission in Crohn's Disease: A UK Single Center Experience

被引：0
|
作者：
Bhandare, Anirudh Pramod [1 ]
Crooks, Benjamin [1 ,2 ]
Taylor, Jo [1 ]
Limdi, Jimmy K. [1 ,2 ,3 ]
机构：
[1] Northern Care Alliance, Salford, Lancs, England
[2] Univ Manchester, Manchester, Lancs, England
[3] Manchester Metropolitan Univ, Manchester, Lancs, England
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PP 0273
引用
收藏
页码：210 / 210
页数：1
相关论文
共 50 条
  • [21] Crohn's Disease: Induction and Maintenance Therapy with Ustekinumab
    Lorenz, Judith
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (01): : 14 - +
  • [22] Experience with ustekinumab in reservoir Crohn's disease
    Martinez Burgos, Maria
    Angulo McGrath, Isabela
    Amo Trillo, Victor
    Olmedo Martin, Raul
    Romero Cara, Patricia
    Mostazo Torres, Jose
    Jimenez Perez, Miguel
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2022, 114 (04) : 233 - 234
  • [23] Ustekinumab in Crohn's disease: experience from a single tertiary centre
    Kiat, C.
    Stanley, E.
    Bailey, Y.
    Breslin, N.
    McNamara, D.
    Ryan, B.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S245 - S245
  • [24] Ustekinumab in resistant Crohn's disease: 1-year UK IBD tertiary referral centre 'real-world' experience
    Borg-Bartolo, S. P.
    Kemp, K.
    Willert, R. P.
    Makin, A. J.
    Levison, S. E.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S464 - S465
  • [25] Ustekinumab for the treatment of perianal Crohn's disease. A real-world experience in a Spanish hospital
    Algara San Nicolas, M.
    Masedo Gonzalez, A.
    Gomez Gomez, G. J.
    Yela San Bernardino, C.
    Casis Herce, B.
    Martinez Montiel, M. P.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S542 - S542
  • [26] Real-World Ustekinumab Experience in Ileum-Dominant Versus Colonic Crohn's Disease
    Vien, Sandy
    Arteaga, Elvis Jovanie
    Grandhe, Sirisha
    Yang, Nuen Tsang
    Mao, Eric J.
    CROHNS & COLITIS 360, 2024, 6 (04)
  • [27] REAL WORLD EXPERIENCE: CLINICAL OUTCOMES AFTER RISANKIZUMAB INDUCTION FOR CROHN'S DISEASE
    Sauk, Jenny S.
    Keyashian, Kian
    Parian, Alyssa M.
    Limsui, David
    Nayeb-Hashemi, Hamed
    Briggs, Kristi
    Kim, Sowon
    Yin, Xiaoxiao
    Trujillo, Sophie
    Chowdhury, Reezwana
    Sharma, Sowmya
    Ho, Andrew
    Park, Sunhee
    Lazarev, Mark
    Limketkai, Berkeley N.
    GASTROENTEROLOGY, 2024, 166 (05) : S1149 - S1149
  • [28] Ustekinumab Use in Crohn's Disease: Real-Life Canadian Experience
    Greenup, Astrid-Jane
    Rosenfeld, Greg
    Bressler, Brian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S334 - S335
  • [29] Tolerability of Ustekinumab in Induction and Maintenance for the Treatment of Crohn's Disease
    Loftus, Edward V., Jr.
    Sattin, Bernie
    Jacobstein, Douglas
    Gasink, Christopher
    Sloan, Sheldon
    Feagan, Brian G.
    Colombel, Jean-Frederic
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S364 - S364
  • [30] Tolerability of Ustekinumab in Induction and Maintenance for the Treatment of Crohn's Disease
    Edward, Loftus Jr
    Bernie, Sattin
    Douglas, Jacobstein
    Christopher, Gasink
    Sheldon, Sloan
    Brian, Feagan
    Jean-Frederic, Colombel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S23 - S24
12345